Mankind Pharma has successfully acquired Bharat Serums and Vaccines (BSV) for INR 13,768 crores. This deal will help Mankind Pharma become a top player in the Indian women’s health and fertility market.
BSV has been a leader in biopharmaceuticals for over 50 years. It has developed important products in women’s health, fertility, and critical care. Mankind Pharma will also benefit from BSV’s research and development (R&D) expertise.
Also read | SurveyMonkey Opens New Office in Bengaluru
With this acquisition, Mankind Pharma plans to expand its business in India and internationally. The company is optimistic about future growth in women’s health and other specialized medicines.
